Clinical Trial Update: A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating PT027 (budesonide/albuterol sulfate) inhaler vs placebo in adults with asthma and exercise-induced bronchoconstriction has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• PT027 Budesonide/Albuterol Sulfate MDI (budesonide and albuterol sulfate)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Exercise-Induced | Phase 3 | Status: COMPLETED | Results posted: 2025-08-27